Quality of care in patients with chronic hepatitis C virus infection: A cohort study

Annals of Internal Medicine

Volumn 153, Issue 4, 2010, Pages 231-239

  Kanwal, Fasiha ^a   Schnitzler, Mark S ^b   Bacon, Bruce R ^b   Hoang, Tuyen ^a   Buchanan, Paula M ^b   Asch, Steven M ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME; ANTIVIRUS AGENT; HEPATITIS A VACCINE; HEPATITIS B VACCINE;

ADULT; AGING; ARTICLE; COMORBIDITY; DATA BASE; FEMALE; HEALTH CARE QUALITY; HEALTH INSURANCE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; CLINICAL PRACTICE; COHORT ANALYSIS; ETHNOLOGY; GENETICS; GENOTYPE; HEPATITIS C VIRUS; MEDICARE; MIDDLE AGED; PRIMARY HEALTH CARE; SPECIALIZATION; UNITED STATES; VIREMIA; VIROLOGY; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; COHORT STUDIES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS A VACCINES; HEPATITIS B VACCINES; HEPATITIS C, CHRONIC; HUMANS; MALE; MEDICARE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; QUALITY INDICATORS, HEALTH CARE; RETROSPECTIVE STUDIES; SPECIALIZATION; UNITED STATES; VIRAL LOAD; VIREMIA;

EID: 77956400350     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-153-4-201008170-00005     Document Type: Article

References (29)

1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705-14. [PMID: 16702586]
2. Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002;36:227-42. [PMID: 12085369] (Pubitemid 34700782)
3. Poynard T, McHutchison J, Manns M, Trepo C, Lindsay K, Goodman Z, et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology. 2002;122:1303-13. [PMID: 11984517] (Pubitemid 34465173)
4. Shiratori Y, Ito Y, Yokosuka O, Imazeki F, Nakata R, Tanaka N, et al; Tokyo-Chiba Hepatitis Research Group. Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival. Ann Intern Med. 2005;142:105-14. [PMID: 15657158]
5. Centers for Medicare & Medicaid Services. Overview: Physician Quality Reporting Initiative. Accessed at www.cms.hhs.gov/pqri/ on 14 June 2010.
6. Kanwal F, Hoang T, Spiegel BM, Eisen S, Dominitz JA, Gifford A, et al. Predictors of treatment in patients with chronic hepatitis C infection - role of patient versus nonpatient factors. Hepatology. 2007;46:1741-9. [PMID: 18046707]
7. Shim M, Khaykis I, Park J, Bini EJ. Susceptibility to hepatitis A in patients with chronic liver disease due to hepatitis C virus infection: missed opportunities for vaccination. Hepatology. 2005;42:688-95. [PMID: 16104047] (Pubitemid 41233663)
8. Dominitz JA, Boyko EJ, Koepsell TD, Heagerty PJ, Maynard C, Sporleder JL, et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology. 2005;41:88-96. [PMID: 15619249] (Pubitemid 40066386)
9. Rousseau CM, Ioannou GN, Todd-Stenberg JA, Sloan KL, Larson MF, Forsberg CW, et al. Racial differences in the evaluation and treatment of hepatitis C among veterans: a retrospective cohort study. Am J Public Health. 2008;98:846-52. [PMID: 18382007]
10. Butt AA, Justice AC, Skanderson M, Rigsby MO, Good CB, Kwoh CK. Rate and predictors of treatment prescription for hepatitis C. Gut. 2007;56:385-9. [PMID: 17005764] (Pubitemid 46579770)
11. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL Jr, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975-82. [PMID: 12324553]
12. Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, Marcellin P, et al; PEGASYS International Study Group. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med. 2004;140:346-55. [PMID: 14996676]
13. Yoshida H, Arakawa Y, Sata M, Nishiguchi S, Yano M, Fujiyama S, et al. Interferon therapy prolonged life expectancy among chronic hepatitis C patients. Gastroenterology. 2002;123:483-91. [PMID: 12145802] (Pubitemid 34827193)
14. Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med. 1998;338:286-90. [PMID: 9445408]
15. Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49:1335-74. [PMID: 19330875]
16. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-9. [PMID: 1607900]
17. el-Serag HB, Kunik M, Richardson P, Rabeneck L. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology. 2002;123:476-82. [PMID: 12145801]
18. Volk ML, Tocco R, Saini S, Lok AS. Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology. 2009;50:1750-5. [PMID: 19824079]
19. Ayanian JZ, Landrum MB, Guadagnoli E, Gaccione P. Specialty of ambulatory care physicians and mortality among elderly patients after myocardial infarction. N Engl J Med. 2002;347:1678-86. [PMID: 12444183]
20. Katon W, Von Korff M, Lin E, Walker E, Simon GE, Bush T, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA. 1995;273:1026-31. [PMID: 7897786]
21. Puoti C, Magrini A, Stati T, Rigato P, Montagnese F, Rossi P, et al. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology. 1997;26:1393-8. [PMID: 9397976] (Pubitemid 27520001)
22. Puoti C, Stati T, Magrini A, Rigato P, Romagnoli G, Rossi P, et al. Liver histology in anti-HCV positive subjects with normal ALT levels [Letter]. Ital J Gastroenterol Hepatol. 1997;29:383-4. [PMID: 9476196]
23. Lanza LL, Walker AM, Bortnichak EA, Dreyer NA. Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study. Arch Intern Med. 1995;155:1371-7. [PMID: 7794085]
24. Wong V, Wreghitt TG, Alexander GJ. Prospective study of hepatitis B vaccination in patients with chronic hepatitis C. BMJ. 1996;312:1336-7. [PMID: 8646046] (Pubitemid 26158305)
25. Centers for Disease Control and Prevention (CDC). Hepatitis B vaccination coverage among adults-United States, 2004. MMWR Morb Mortal Wkly Rep. 2006;55:509-11. [PMID: 16691181]
26. Rongey CA, Kanwal F, Hoang T, Gifford AL, Asch SM. Viral RNA testing in hepatitis C antibody-positive veterans. Am J Prev Med. 2009;36:235-8. [PMID: 19162434]
27. Hachem CY, Kramer JR, Kanwal F, El-Serag HB. Hepatitis vaccination in patients with hepatitis C: practice and validation of codes at a large Veterans Administration Medical Centre. Aliment Pharmacol Ther. 2008;28:1078-87. [PMID: 18691350]
28. Hernandez B, Hasson NK, Cheung R. Hepatitis C performance measure on hepatitis A and B vaccination: missed opportunities? Am J Gastroenterol. 2009;104:1961-7. [PMID: 19491840]
29. Ong JP, Collantes R, Pitts A, Martin L, Sheridan M, Younossi ZM. High rates of uninsured among HCV-positive individuals. J Clin Gastroenterol. 2005; 39:826-30. [PMID: 16145347] (Pubitemid 41361902)